UBS Group
INSM icon

UBS Group’s Insmed INSM Stock Holding History

UBS Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45,600
Closed -$7.94M – 10818
2025
Q4 		$7.94M Sell
45,600
-2,600
-5% -$474K ﹤0.01% 3544
2025
Q3 		$6.94M Sell
48,200
-41,800
-46% -$5.12M ﹤0.01% 3691
2025
Q2 		$9.06M Buy
90,000
+79,400
+749% +$6.07M ﹤0.01% 3179
2025
Q1 		$809K Sell
10,600
-81,600
-89% -$6.24M ﹤0.01% 5463
2024
Q4 		$6.37M Sell
92,200
-36,000
-28% -$2.59M ﹤0.01% 3558
2024
Q3 		$9.36M Hold
128,200
– – ﹤0.01% 2432
2024
Q2 		$8.59M Buy
+128,200
New +$4.97M ﹤0.01% 2348

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

UBS Group's INSM Position: Q1 2026 in Review

UBS Group reduced its Insmed (INSM) stake by 7% in Q1 2026, selling an estimated $20M and leaving 1,737,481 shares worth $284M. The position accounts for 0.04% of the portfolio, ranked #454.

UBS Group first reported a position in INSM in Q4 2014 and has held it in 46 quarters since. The position peaked at $325M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • UBS Group held 1,737,481 shares of Insmed worth $284M as of Q1 2026.
  • UBS Group sold 130,154 Insmed shares in Q1 2026, an estimated $20M.
  • Insmed made up 0.04% of UBS Group's portfolio in Q1 2026, its #454 holding.
  • UBS Group first reported a position in Insmed in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Insmed position peaked at $325M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.